Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

The Lancet(2022)

引用 46|浏览25
暂无评分
摘要
UK National Institute for Health and Care Research.
更多
查看译文
关键词
ischaemic heart disease,heart disease,uk patients,all-heart,open-label,blinded-endpoint
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要